Overall Survival and Updated Results from a Phase II Study of Sunitinib in Japanese Patients with Metastatic Renal Cell Carcinoma

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyq146 ◽

2010 ◽

Vol 40 (12) ◽

pp. 1166-1172 ◽

Author(s):

Y. Tomita ◽

N. Shinohara ◽

T. Yuasa ◽

H. Fujimoto ◽

M. Niwakawa ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Overall Survival ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Phase Ii Study ◽

Japanese Patients

Download Full-text

A Phase II Study of Sunitinib in Japanese Patients with Metastatic Renal Cell Carcinoma: Insights into the Treatment, Efficacy and Safety

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyp146 ◽

2009 ◽

Vol 40 (3) ◽

pp. 194-202 ◽

Author(s):

H. Uemura ◽

N. Shinohara ◽

T. Yuasa ◽

Y. Tomita ◽

H. Fujimoto ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Treatment Efficacy ◽

Phase Ii Study ◽

Japanese Patients ◽

Efficacy And Safety

Download Full-text

Key predictive factors of axitinib (AG-013736)-induced proteinuria and efficacy: A phase II study in Japanese patients with cytokine-refractory metastatic renal cell Carcinoma

European Journal of Cancer ◽

10.1016/j.ejca.2011.07.014 ◽

2011 ◽

Vol 47 (17) ◽

pp. 2592-2602 ◽

Author(s):

Yoshihiko Tomita ◽

Hirotsugu Uemura ◽

Hiroyuki Fujimoto ◽

Hiro-omi Kanayama ◽

Nobuo Shinohara ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Predictive Factors ◽

Phase Ii Study ◽

Japanese Patients

Download Full-text

Overall survival and final efficacy and safety results from a Japanese phase II study of axitinib in cytokine‐refractory metastatic renal cell carcinoma

Cancer Science ◽

10.1111/cas.12546 ◽

2014 ◽

Vol 105 (12) ◽

pp. 1576-1583 ◽

Author(s):

Masatoshi Eto ◽

Hirotsugu Uemura ◽

Yoshihiko Tomita ◽

Hiroomi Kanayama ◽

Nobuo Shinohara ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Overall Survival ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Phase Ii Study ◽

Efficacy And Safety

Download Full-text

Overall survival of first-line axitinib in metastatic renal cell carcinoma: Japanese subgroup analysis from phase II study

Cancer Science ◽

10.1111/cas.13232 ◽

2017 ◽

Vol 108 (6) ◽

pp. 1231-1239 ◽

Author(s):

Mototsugu Oya ◽

Yoshihiko Tomita ◽

Satoshi Fukasawa ◽

Nobuo Shinohara ◽

Tomonori Habuchi ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Overall Survival ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Subgroup Analysis ◽

Phase Ii Study ◽

Download Full-text

A phase II study of the efficacy and safety of sunitinib in Japanese patients with metastatic renal cell carcinoma (mRCC)

UroToday International Journal ◽

10.3834/uij.1939-4810.2008.09.12 ◽

2008 ◽

Vol 01 (03) ◽

Author(s):

H Uemura ◽

N Shinohara ◽

S Naito ◽

H Akaza

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Phase Ii Study ◽

Japanese Patients ◽

Efficacy And Safety

Download Full-text

A phase II study of the efficacy and safety of sunitinib in treatment-naïve and pretreated Japanese patients (pts) with metastatic renal cell carcinoma (mRCC)

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.16108 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 16108-16108 ◽

Author(s):

H. Uemura ◽

N. Shinohara ◽

S. Naito ◽

H. Akaza

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Phase Ii Study ◽

Japanese Patients ◽

Efficacy And Safety ◽

Treatment Naïve

Download Full-text

RANDOMIZED PHASE II STUDY OF FIRST-LINE EVEROLIMUS (EVE) + BEVACIZUMAB (BEV) VERSUS INTERFERON ALFA-2A (IFN) + BEV IN PATIENTS (PTS) WITH METASTATIC RENAL CELL CARCINOMA (MRCC): RECORD-2

Annals of Oncology ◽

10.1093/annonc/mds399 ◽

2012 ◽

Vol 23 ◽

pp. ix258 ◽

Author(s):

A. Ravaud ◽

C. Barrios ◽

Ö. Anak ◽

D. Pelov ◽

A. Louveau ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Phase Ii Study ◽

Interferon Alfa ◽

Randomized Phase Ii

Download Full-text

Cyclic Interf eron Alpha Treatment in Metastatic Renal Cell Carcinoma: Results of a Phase II Study and Review of the Literature

Urologia Internationalis ◽

10.1159/000282937 ◽

1997 ◽

Vol 58 (1) ◽

pp. 8-12 ◽

Author(s):

Georg Hofmockel ◽

Winfried Tack ◽

Hubert G.W. Frohmüller

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Phase Ii Study ◽

Review Of The Literature

Download Full-text

An early phase II trial of S-1 in Japanese patients with cytokine-refractory metastatic renal cell carcinoma

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-010-1262-8 ◽

2010 ◽

Vol 66 (6) ◽

pp. 1065-1070 ◽

Author(s):

Seiji Naito ◽

Taiji Tsukamoto ◽

Michiyuki Usami ◽

Hiroyuki Fujimoto ◽

Hideyuki Akaza

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Early Phase ◽

Phase Ii Trial ◽

Japanese Patients

Download Full-text

A Phase II Study of Bevacizumab and Everolimus as Treatment for Refractory Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2012.12.002 ◽

2013 ◽

Vol 11 (2) ◽

pp. 100-106 ◽

Author(s):

Lauren C. Harshman ◽

Sarah Barbeau ◽

Alex McMillian ◽

Sandy Srinivas

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Download Full-text